Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections.

By U. Seybold, E. Kourbatova, James G. Johnson, S. J. Halvosa, Yun F Wang, M. King, S. Ray, H. Blumberg. Clinical Infectious Diseases, 2006

704 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/d7e8ab1f45fdf85fec0bb2b997629cc4dd3a3ccd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

In Infectious Diseases

Citations in the corpus

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. (2008, background): “The spread of these PFGE types in community and healthcare settings may account for some of the increase in colonization with MRSA [9, 42, 43].”
The evolution of Staphylococcus aureus. (2008, background): “However, during recent years, CA-MRSA has started to replace HA-MRSA in healthcare facilities, especially in the USA and Taiwan, where the CA-MRSA prevalence is high (Klevens et al., 2006; Moran et al., 2006; Otter and French, 2006; Seybold et al., 2006; Huang et al., 2007b; Maree et al., 2007).”
The molecular evolution of methicillin-resistant Staphylococcus aureus. (2007, background): “Furthermore, CAMRSA strains have started to replace HA-MRSA in healthcare settings [92,93].”
A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus (2011, neutral): “, bloodstream infections [240].”
Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element (2014, background): “community outbreaks, as well as hospital-acquired infections, is MRSA USA500 (Diep et al., 2006; Seybold et al., 2006; Cocchi et al., 2011; Peters et al., 2011), which has”
Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic (2010, background): “For example, among bloodstream infections in Atlanta, GA, in 2004, 34% of nosocomially transmitted isolates belonged to the USA300 CA-MRSA genotype (820), and in a Detroit, MI, hospital in 2005 to 2007, USA300 accounted for 20% (9/45) of tested nosocomial bloodstream infections (171).”
Waves of resistance: Staphylococcus aureus in the antibiotic era (2009, background): “CA-MRSA clones have also gained a foothold in hospitals and are increasingly being identified as a cause of hospital-onset and heath care-associated infection”